In August xxxx, the Tetra Potassium Pyrophosphate prices saw a x.xx increase in the USA, driven by strong demand from buyers while supply levels were moderate. The demand for Tetra Potassium Pyrophosphate was firm from the pharma sector. The funding in the pharma and healthcare sector surged by xxxx to USD xxx million in August, up from USD xx million in July xxxx. It also represents a xxx increase compared to the USD xxx million raised in August xxxx. Most of this funding, xx.xx, was attributed to late-stage investments, while early-stage and seed-stage rounds contributed xx.xx and x.xx, respectively. Notable funding rounds in August xxxx were reported by Jade Bioscience, Even, and Pharmazz. Furthermore, the US Healthcare sector emerged as the top performer for August xxxx, with business activity growing at its fastest rate since December xxxx. Financials and Industrials also experienced solid output expansion, with Industrials accelerating...
